ACS Latest News Archive

Which Biomarkers Provide Prognostic Information on Mortality in Acute Coronary Syndrome?

Which Biomarkers Provide Prognostic Information on Mortality in Acute Coronary Syndrome?

N-terminal pro-B-type natriuretic peptide and growth differentiation factor-15 provide prognostic information in patients with ACS.

Manual Chest Compressions Superior to Mechanical Alternative for Cardiac Arrest

Manual Chest Compressions Superior to Mechanical Alternative for Cardiac Arrest

Mechanical chest compression devices are not superior to conventional, high-quality manual chest compressions.

Incidence of Myocardial Infarction Found to Increase With Cold Weather

Incidence of Myocardial Infarction Found to Increase With Cold Weather

The influence of weather on the incidence of myocardial infarction was examined.

Race-Based Characteristics May Mediate Differences in Acute Myocardial Infarction Outcomes

Race-Based Characteristics May Mediate Differences in Acute Myocardial Infarction Outcomes

Substantial differences were found between black and white participants in demographic, socioeconomic, psychosocial, clinical, disease severity, and health status characteristics.

CABG Superior to PCI-DES for Reducing All-Cause Mortality in Multivessel Disease With Diabetes

CABG Superior to PCI-DES for Reducing All-Cause Mortality in Multivessel Disease With Diabetes

Coronary artery bypass grafting may be a superior revascularization strategy in patients with diabetes and multivessel disease.

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Very Low High-Sensitivity Cardiac Troponin Levels May Exclude Inducible Myocardial Ischemia

Low hs-cTnI levels may identify patients with CAD who have a low medium-term risk for adverse cardiovascular events.

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Pitavastatin Plus Ezetimibe May Improve Outcomes for ACS Without Hypertension

Combined treatment with pitavastatin and ezetimibe may be beneficial in patients with acute coronary syndrome and without hypertension for secondary prevention.

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Influenza Infection Increases Mortality Risk in Acute Myocardial Infarction

Investigators examined whether influenza is an independent risk factor for the development of acute myocardial infarction.

Strong Association Found Between Antiphospholipid Antibodies and First-Time MI

Strong Association Found Between Antiphospholipid Antibodies and First-Time MI

A strong association between antiphospholipid positivity and first-time MI may represent a risk factor for myocardial infarction.

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

Canagliflozin Approved to Reduce MACE Risk in Adults With Type 2 Diabetes and CVD

The FDA has approved Invokana (canagliflozin) to reduce the risk of major CV events.

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

Point-of-Care Troponin Assay Facilitates Rapid Risk Stratification in Acute MI

A novel point-of-care assay was shown to provide results within 15 minutes, thereby facilitating rapid risk stratification of patients with suspected acute MI.

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

Coronary CTA Reliably Assesses Long-Term Cardiovascular Risk

Coronary computed tomography angiography is a reliable tool to assess long-term cardiovascular risk in suspected CCS.

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

Complete Revascularization Superior to Culprit-Only Intervention in NSTEMI

Single-stage complete coronary revascularization appears to be superior to culprit-only lesion intervention in multivessel disease ACS.

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

Variable Period of Risk for Myocardial Infarction and Stroke Following Sepsis

Patients recovering from sepsis had an elevated risk for myocardial infarction or stroke in the first 4 weeks after hospital discharge compared to the general population.

Outcomes of Undetected Myocardial Infarction Examined

Outcomes of Undetected Myocardial Infarction Examined

Unrecognized MI detected by cardiac magnetic resonance imaging has similar mortality rates over the long term compared with recognized MI.

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

No Differences Between Bivalirudin, UFH Post-PCI After Ticagrelor Pretreatment

There is no difference between heparin and bivalirudin in terms of platelet aggregation or coagulation markers after pretreatment with ticagrelor in patients undergoing PPCI.

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

Risk for Acute Myocardial Infarction Increased in Multiple Sclerosis

Evidence suggests a possible role for inflammation in the association between MS and myocardial infarction risk.

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

Same Day Discharge Post-Elective PCI Safe and Generates Cost Savings

Same day hospital discharge has the potential increase the overall value of PCI care and save US hospitals approximately $577 million if implemented more consistently.

Rivaroxaban Associated With Reduced D-Dimer Levels in Acute Coronary Syndrome

Rivaroxaban Associated With Reduced D-Dimer Levels in Acute Coronary Syndrome

Elevated baseline D-dimer levels were associated with an increased risk for adverse cardiovascular outcomes.

In-Hospital Corticosteroid Treatment for Pneumonia May Reduce MI Incidence

In-Hospital Corticosteroid Treatment for Pneumonia May Reduce MI Incidence

In-hospital treatment of adult community-acquired pneumonia with corticosteroids may be associated with a lower MI risk.

QRS-T Angle Improves Diagnostic Accuracy of NSTEMI, Predicts Mortality Risk

QRS-T Angle Improves Diagnostic Accuracy of NSTEMI, Predicts Mortality Risk

The use of the QRS-T angle with standard ECG criteria improved diagnostic accuracy for NSTEMI.

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

ACE Inhibitors Reduce MACE Incidence in NSTEMI Post-Successful PCI

Angiotensin-converting enzyme inhibitors reduced the incidence of revascularization and major adverse cardiac events, but had no beneficial effect on total deaths or recurrence of myocardial infarction.

Revisiting the Clinical Utility of High Sensitivity Cardiac Troponin I Assays

Revisiting the Clinical Utility of High Sensitivity Cardiac Troponin I Assays

The effects of using high-sensitivity cardiac troponin I assays in patients with suspected acute coronary syndrome were assessed.

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor Without Concomitant Aspirin No Better Than Standard DAPT in PCI

Ticagrelor without aspirin offered no additional benefits compared with conventional dual antiplatelet therapy in patients undergoing PCI for either CAD or ACS.

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Radial Access Reduced Adverse Events in Intervention for Acute Coronary Syndrome

Net adverse cardiac events occurred in 15.2% of patients with radial access and 17.2% with femoral access while undergoing invasive therapies for acute coronary syndrome.

Low Rates of Increasing Statin Doses After MI in Diabetes

Low Rates of Increasing Statin Doses After MI in Diabetes

Up-titration to a high-intensity statin occurred in only 37.7% of patients with diabetes after an acute myocardial infarction.

Rapid MI Rule-Out Protocol Outperforms Older Assay

Rapid MI Rule-Out Protocol Outperforms Older Assay

The new rapid rule-out for MI protocol had sensitivity and negativity predictive values of 100% and a specificity of 86%.

Outcomes of Beta-Blocker Use Elderly With Diabetes After Heart Attack

Outcomes of Beta-Blocker Use Elderly With Diabetes After Heart Attack

Investigators examined the outcomes of using various beta-blockers in patients with type 2 diabetes after a myocardial infarction.

Acute Coronary Syndrome Risk Elevated in Siblings of Patients With RA

Acute Coronary Syndrome Risk Elevated in Siblings of Patients With RA

Siblings of patients with rheumatoid arthritis appear to have an increased risk for acute coronary syndrome, which suggests there is a shared susceptibility between the 2 conditions.

Dabigatran May Reduce Major Vascular Complication Risk After Noncardiac Surgery

Dabigatran May Reduce Major Vascular Complication Risk After Noncardiac Surgery

Dabigatran may be associated with a risk reduction of major vascular complications in patients who develop a myocardial injury after noncardiac surgery.

Acute MI Diagnosis: 0/1 Hour Superior to 0/3 Hour Algorithm

Acute MI Diagnosis: 0/1 Hour Superior to 0/3 Hour Algorithm

The 0/1 hour algorithm was superior to the 0/3 hour algorithm for ruling out acute myocardial infarction.

Cardiovascular Outcomes in Patients With ACS, Diabetes Using Alirocumab

Cardiovascular Outcomes in Patients With ACS, Diabetes Using Alirocumab

Investigators examine the effects of the PCSK9 inhibitor alirocumab in patients with recent acute coronary syndrome and diabetes.

NSTEMI Risk for ICU Complications Predicted Using ACTION ICU Risk Score

NSTEMI Risk for ICU Complications Predicted Using ACTION ICU Risk Score

When patient risk was predicted using ACTION ICU model, the likelihood of a complication developing that required ICU care increased >10-fold from the lowest to the highest scores.

Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure

Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure

Aldosterone antagonists significantly reduced the risk for mortality in patients with ST-segment elevation myocardial infarction without heart failure.

Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes

Safety of DPP-IV Inhibitor, Cardiovascular Events After ACS in Type 2 Diabetes

Investigators examined the time to first event composing of cardiovascular death, myocardial infarction, or stroke.

CV Risks With Alogliptin in Type 2 Diabetes and Recent Acute Coronary Syndrome

CV Risks With Alogliptin in Type 2 Diabetes and Recent Acute Coronary Syndrome

Investigators conducted a randomized, double-blinded, placebo-trolled trial in patients with T2D after an acute coronary syndrome.

Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes

Liraglutide May Affect Clinical Outcomes of Myocardial Infarction in Type 2 Diabetes

Liraglutide may reduce the incidence of myocardial infarction in patients who have a high cardiovascular risk with type 2 diabetes.

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Oxygen Therapy in Acute MI Not Associated With Clinical Benefit

Patients with confirmed or suspected acute myocardial infarction do not benefit from supplemental oxygen therapy.

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Loading Atorvastatin Doses Before and After PCI in ACS for MACE Prevention

Major adverse cardiovascular events were not reduced in patients with acute coronary syndrome undergoing planned percutaneous coronary intervention when given 2 loading doses of atorvastatin.

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Statin Prescription Trends in Women vs Men After Hospitalization for MI

Women are less likely than men to fill a high-intensity statin prescription following hospitalization for myocardial infarction.

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Smoking Cessation Rates in Acute Coronary Syndrome With Varenicline

Although varenicline was effective for short-term smoking cessation, more than half of the patients in the EVITA trial relapsed after 1 year.

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Machine Learning Shows Potential in Diagnosing Myocardial Infarction in Patients With Chest Pain

Two analyses were conducted, one during the training phase and the second during the validation phase of the study.

Strongest Predictors of STEMI Adverse Outcomes in Cardiogenic Shock

Strongest Predictors of STEMI Adverse Outcomes in Cardiogenic Shock

Time from first medical contact to primary percutaneous coronary intervention is inversely linked to short-term survival in STEMI.

Acute MI With Diabetes Mortality Predicted by Acute-to-Chronic Glycemic Ratio

Acute MI With Diabetes Mortality Predicted by Acute-to-Chronic Glycemic Ratio

In patients with diabetes who had an acute myocardial infarction, the acute-to-chronic glycemic ratio was a better predictor of mortality compared with baseline glycemia levels.

Clopidogrel Tablets Recalled Due to Mislabeling

Clopidogrel Tablets Recalled Due to Mislabeling

One lot of clopidogrel, a platelet inhibitor, has been recalled due to mislabeling.

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Multivessel CAD With Diabetes: Choosing an Optimal Revascularization Strategy

Patients with multivessel coronary artery disease and diabetes may benefit more from coronary artery bypass grafting surgery vs percutaneous coronary intervention.

ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management

ACC/AHA Release 2017 Quality Measures for STEMI/NSTEMI Management

The American College of Cardiology and the American Heart Association have released updated quality and performance measures for STEMI and NSTEMI management.

Coronary Artery Disease, MI Risk With Abacavir-containing ART

Coronary Artery Disease, MI Risk With Abacavir-containing ART

The researchers concluded abacavir-containg ART does not increase the risk of coronary artery disease or myocardial infarction

New ESC Guidelines Provide Insight into ST-Segment Elevation Management

New ESC Guidelines Provide Insight into ST-Segment Elevation Management

The European Society of Cardiology has released new guidelines regarding treatment strategies for acute myocardial infarction and STEMI.

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

Comparison of PCI Outcomes With Bivalirudin vs Heparin Post-STEMI or NSTEMI

In patients undergoing percutaneous coronary intervention for either STEMI or NSTEMI, bivalirudin and heparin produce similar outcomes.

Suspected MI: No Difference Between Supplemental Oxygen and Ambient Air Treatment

Suspected MI: No Difference Between Supplemental Oxygen and Ambient Air Treatment

Supplemental oxygen therapy does not decrease the risk for 1-year all-cause mortality in patients with suspected myocardial infarction.

Atherosclerotic Disease Benefits From Interleukin-1β Targeting

Atherosclerotic Disease Benefits From Interleukin-1β Targeting

In high-risk patients with atherosclerotic disease, canakinumab may help reduce the incidence of cardiovascular events.

Early vs Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

Early vs Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

In patients with non-ST-elevation acute coronary syndromes, an early invasive treatment strategy does not significantly reduce mortality rates.

Elevated High-Sensitivity Troponin T in Afib May Not Increase Coronary Event Risk

Elevated High-Sensitivity Troponin T in Afib May Not Increase Coronary Event Risk

Patients with atrial fibrillation but without known coronary artery disease may not be at an increased risk for coronary events, despite elevated high-sensitivity troponin T levels.

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

Can Beta-Blockers Reduce Mortality in Acute Myocardial Infarction Without Heart Failure?

In patients with acute myocardial infarction without heart failure, beta-blockers did not reduce mortality risk at 1 year.

Chronic Angina Therapy Gets Fast Track Designation From FDA

Chronic Angina Therapy Gets Fast Track Designation From FDA

XyloCor's XC001 is a potential therapy for patients with chronic angina.

Single High-Sensitivity Cardiac Troponin T Measurement Could Rule Out Acute Myocardial Infarction

Single High-Sensitivity Cardiac Troponin T Measurement Could Rule Out Acute Myocardial Infarction

Sensitivity of the acute myocardial infarction risk classification ranged from 87.5% to 100%, and the pooled sensitivity estimate was 98.7%.

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Compared with New York counties without trans fatty acid restrictions, those with restrictions showed a significantly greater decline in combined myocardial infarction and stroke events.

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

Cardiac Magnetic Resonance Improves Diagnosis in Cardiac Arrest Survivors

Cardiac magnetic resonance was superior to transthoracic echocardiogram in identifying a pathologic substrate in patients with out-of-hospital cardiac arrest.

Long-term Cardiovascular Risk of Undiagnosed Chest Pain

Long-term Cardiovascular Risk of Undiagnosed Chest Pain

Patients with undiagnosed chest pain in primary care rarely undergo diagnostic testing, but experience an increased risk of both fatal and non-fatal CV events.

Women With STEMI Experience Treatment Delays

Women With STEMI Experience Treatment Delays

Women with ST-segment elevation myocardial infarction often experience prehospital delays to reperfusion.

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial Fibrillation Associated With Higher Mortality in STEMI

Atrial fibrillation was associated with a higher risk of adjusted in-hospital mortality and bleeding complications after both PCI and CABG.

Elevated Mortality Risk in Women With Acute Coronary Syndrome

Elevated Mortality Risk in Women With Acute Coronary Syndrome

Data from almost 15,000 patients were analyzed to determine the links among age, acute coronary syndrome severity, and 30-day mortality.

Acute Coronary Syndrome Risk Reduced With Pioglitazone in Insulin Resistance Post-Stroke

Acute Coronary Syndrome Risk Reduced With Pioglitazone in Insulin Resistance Post-Stroke

Pioglitazone reduced the risk of acute coronary syndromes, including type 1 myocardial infarction.

ST-Segment Elevation Myocardial Infarction Symptom Presentation With Diabetes

ST-Segment Elevation Myocardial Infarction Symptom Presentation With Diabetes

Patients with diabetes presented with ST-segment elevation myocardial infarction symptoms, on average, 50 minutes later than patients without diabetes.

Incidence of Cardiogenic Shock in ST-Segment Elevated Myocardial Infarction

Incidence of Cardiogenic Shock in ST-Segment Elevated Myocardial Infarction

In-hospital mortality was elevated among those who presented with cardiogenic shock during their index hospitalization.

Effects of Vitamin D on High-Intensity Statin Therapy for Coronary Artery Disease

Effects of Vitamin D on High-Intensity Statin Therapy for Coronary Artery Disease

Significantly decreased platelet reactivity occurred in patients who were given a new statin or an increased dose of a previous statin.

MI Risk Reduced in Rheumatoid Arthritis With TNFi Drugs

MI Risk Reduced in Rheumatoid Arthritis With TNFi Drugs

Tumor necrosis factor-α inhibiting drugs were shown to reduce the risk of myocardial infarction in rheumatoid arthritis.

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

Timing of Noncardiac Surgery Following Percutaneous Coronary Intervention

Although current guidelines recommend delaying noncardiac surgery for 6 to 12 months after drug-eluting stent implantation, new data suggest surgery may be performed earlier.

Shared Decision Making in Acute Coronary Syndrome

Shared Decision Making in Acute Coronary Syndrome

Patients in the shared decision making group had greater knowledge about their risk for acute coronary syndrome and options for care.

Suicide Risk in Acute Coronary Syndrome

Suicide Risk in Acute Coronary Syndrome

Patients with acute coronary syndrome had significantly higher odds of committing suicide compared with healthy individuals.

Protective Effect of PCSK9 and HMGCR on CV Events, Diabetes Risk

Protective Effect of PCSK9 and HMGCR on CV Events, Diabetes Risk

PCKS9 and HMGCR variants were associated with similar protective effects on cardiovascular event risk and diabetes risk.

Cangrelor Alone Reduces Bleeding Risk Compared With Clopidogrel and GPIs

Cangrelor Alone Reduces Bleeding Risk Compared With Clopidogrel and GPIs

The cangrelor alone and clopidogrel-GPI groups did not have significantly different rates of the primary efficacy end point.

Choosing the Ideal STEMI Treatment Strategy: Pharmacoinvasive vs PCI

Choosing the Ideal STEMI Treatment Strategy: Pharmacoinvasive vs PCI

Using primary percutaneous coronary intervention or a pharmacoinvasive strategy results in similar outcomes for patients with STEMI.

PCI of Concurrent Coronary Chronic Total Occlusion After STEMI

PCI of Concurrent Coronary Chronic Total Occlusion After STEMI

PCI in patients with chronic total occlusion of the left anterior descending coronary artery had significantly improved LVEF compared with control patients.

Cangrelor Reduces PCI Complications in ACS, Stable Angina

Cangrelor Reduces PCI Complications in ACS, Stable Angina

Cangrelor provided similar perioprocedural benefits, as well as reduced risk of bleeding, as clopidogrel in patients with stable angina and acute coronary syndromes.

Pinpointing Potentially Preventable Acute MI and HF Hospital Readmissions

Pinpointing Potentially Preventable Acute MI and HF Hospital Readmissions

Researchers studied patients with acute MI or heart failure to determine if any postdischarge readmissions were potentially preventable.

Comparison of Risk Associated With STEMI vs NSTEMI

Comparison of Risk Associated With STEMI vs NSTEMI

STEMI patients were more likely to receive PCI, but mortality risk was still increased after multivariable adjustment, compared with NSTEMI patients.

STEMI During "Off-Hours" Does Not Lead to Worse Outcomes

STEMI During "Off-Hours" Does Not Lead to Worse Outcomes

Patients with STEMI who present off-hours do not have worse outcomes than those who present during the workday.

Long-Term DAPT Reduced MACE After Complex PCI

Long-Term DAPT Reduced MACE After Complex PCI

Long-term dual antiplatelet therapy was associated with reduced MACE in patients who underwent complex percutaneous coronary intervention.

DAPT Duration After PCI: Similar Outcomes for Women and Men

DAPT Duration After PCI: Similar Outcomes for Women and Men

After multivariate adjustment for baseline imbalances, researchers found no significant differences for the primary efficacy end point between genders.

Smoking Status Influence on Clopidogrel Response

Smoking Status Influence on Clopidogrel Response

Researchers observed a "significant inverse correlation" between P2Y12 reaction units and hemoglobin.

Thrombocytopenia Risk in Tirofiban vs Heparin

Thrombocytopenia Risk in Tirofiban vs Heparin

Rate of thrombocytopenia was significantly higher for patients assigned to phosphate-buffered tirofiban, but not those assigned to unfractionated heparin or citrate-buffered tirofiban.

High-Sensitivity Troponin Testing May Not Alter Outcomes in Chest Pain

High-Sensitivity Troponin Testing May Not Alter Outcomes in Chest Pain

High-sensitivity reporting did not reduce death or new or recurrent acute coronary syndrome compared with standard reporting.

LV End-Diastolic Volume Index Did Not Change With Bioresorbable Cardiac Matrix

LV End-Diastolic Volume Index Did Not Change With Bioresorbable Cardiac Matrix

No significant differences in the primary or safety outcomes with either bioresorbable cardiac matrix or saline.

AHA Intervention Project Improves Adherence to STEMI Guidelines

AHA Intervention Project Improves Adherence to STEMI Guidelines

The proportion of patients who presented directly to a PCI-capable center treated within STEMI guideline goals increased from 59% to 61%.

High-Dose Omega-3 Fatty Acids Reduced Adverse Events After MI

High-Dose Omega-3 Fatty Acids Reduced Adverse Events After MI

OMEGA-REMODEL study results found an association between omega-3 fatty acids and reduction in adverse effects after acute MI.

ACTION Registry-GWTG Database Predicted In-Hospital Mortality Following Acute MI

ACTION Registry-GWTG Database Predicted In-Hospital Mortality Following Acute MI

The parsimonious risk model is a valid instrument for risk adjustment and risk stratification in acute myocardial infarction.

MI After Noncardiac Surgery Linked to High Mortality Risk After PCI

MI After Noncardiac Surgery Linked to High Mortality Risk After PCI

Myocardial infarction was associated with a high mortality rate even after percutaneous coronary intervention.

Acute Coronary Syndrome With Diabetes May Increase Adverse Event Risk

Acute Coronary Syndrome With Diabetes May Increase Adverse Event Risk

Researchers conducted an analysis to investigate major adverse events in acute coronary syndrome patients with diabetes using data from the PROSPECT study.

Intravascular Brachytherapy for Treatment of In-Stent Restenosis from Drug-Eluting Stent

Intravascular Brachytherapy for Treatment of In-Stent Restenosis from Drug-Eluting Stent

Intravascular brachytherapy may work as a short-term treatment option in patients with recurrent drug-eluting stent in-stent restenosis.

Comparing Bivalirudin Infusion Doses in Percutaneous Coronary Intervention

Comparing Bivalirudin Infusion Doses in Percutaneous Coronary Intervention

A full dose of bivalirudin infusion (1.75 mg/kg/h) may mitigate acute stent thrombosis with an increased risk of major bleeding.

Sleep-Disordered Breathing Increases Risk of Major Cardiocerebrovascular Events Following PCI

Sleep-Disordered Breathing Increases Risk of Major Cardiocerebrovascular Events Following PCI

Sleep-disordered breathing was a significant predictor for MACCE, along with increase in age, decrease in LVEF and mean SaO2, and the absence of either beta-blocker or statin treatment.

Ischemic Memory Imaging With Myocardial Contrast ECG Detects Myocardial Ischemia in Animal Models

Ischemic Memory Imaging With Myocardial Contrast ECG Detects Myocardial Ischemia in Animal Models

Ischemic memory imaging with myocardial contrast echocardiography in non-infarcted tissue is possible in animal models using the complement-mediated interaction between phosphatidylserine -containing microbubbles.

Liraglutide Lowered Cardiovascular Event Rates in Type 2 Diabetes

Liraglutide Lowered Cardiovascular Event Rates in Type 2 Diabetes

LEADER trial results demonstrated that liraglutide lowered first occurrence of death from cardiovascular causes in patients with type 2 diabetes.

Prior Cardiovascular Event Increased Mortality for Type 2 Diabetes Patients

Prior Cardiovascular Event Increased Mortality for Type 2 Diabetes Patients

Heart failure is a particularly powerful predictor of mortality in patients who have both coronary heart disease and type 2 diabetes.

STEMI Outcomes Improve With High Mechanical Index Impulses and Intravenous Microbubbles

STEMI Outcomes Improve With High Mechanical Index Impulses and Intravenous Microbubbles

Researchers tested efficacy and safety of high mechanical index impulses from a diagnostic ultrasound transducer during intravenous microbubble infusion.

Dual Antiplatelet Therapy Score Improved Prediction of Patient Benefit From Continued Therapy

Dual Antiplatelet Therapy Score Improved Prediction of Patient Benefit From Continued Therapy

Previous myocardial infarction was associated with a greater risk for late ischemic events compared to no myocardial infarction history.

COMBO Stent Demonstrates High Procedural Success and Low Revascularization Rates

COMBO Stent Demonstrates High Procedural Success and Low Revascularization Rates

The device success rate with COMBO stent was 98.7% and stenosis of more than 20% occurred after the procedure in 0.9% of patients.

BARC Bleeding Criteria Effectively Predict Mortality in Acute Coronary Syndromes Without STE

BARC Bleeding Criteria Effectively Predict Mortality in Acute Coronary Syndromes Without STE

Bleeding Academic Research Consortium scale can independently predict 1-year mortality in patients with acute coronary syndromes without ST-segment elevation.

Sign Up for Free e-Newsletters